Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720

Immunopharmacology

Volumn 34, Issue 2-3, 1996, Pages 171-179

  Enosawa, Shin ^a   Suzuki, Seiichi ^a   Kakefuda, Toshihiro ^a   Li, Xiao Kang ^a   Amemiya, Hiroshi ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Apoptosis; Cyclophosphamide; FTY720; Immunosuppressant; Rat; T cell depletion

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; NEW DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL DEATH; CELL SPECIFICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE; LIVER; LYMPH NODE CELL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOID ORGAN; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RAT; SPLEEN; T LYMPHOCYTE; THYMUS;

EID: 0030245686     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00132-4     Document Type: Article

References (11)

1. Adachi, K., Kohara, T., Nakao, N., Arita, M., Chiba, K., Mishina, T., Sasaki, S. and Fujita, T., 1995. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720. Bioorg. Med. Chem. Lett. 5: 853-856.
2. Baird, M.A., Enosawa, S. and Heslop, B.F., 1992. Evidence that changes in expression of major histocompatibility complex antigens may underlie the immunosuppressive effect of heat-treated cells in vivo and in vitro. Transplantation 53: 1329-1333.
3. Berger, J., 1980. Leucokinetic study. Morphology of the bone marrow and blood after experimental induction of marrow hypoplasia by cyclophosphamide in laboratory rats. Folia Haematol. 107: 862-877.
4. Chantenoud, L., Jonker, M., Villemain, F., Goldstein, G. and Bach, J.-F., 1986. The human immune response to the OKT3 monoclonal antibody is oligoclonal. Science 232: 1406-1408.
5. Cosimi, A.B., 1987. Clinical development of ORTHOCLONE OKT3. Transplant Proc. 19: 7-16.
6. DeVault, G.A., Jr., Kohan, D.E., Nelson, E.W. and Holman, J.M., Jr., 1994. The effect of oral pentoxifylline on the cytokine release syndrome during inductive OKT3. Transplantation 57: 532-540.
7. Harlow, E. and Lane, D., 1988. Cell staining. In: eds. E. Harlow and D. Lane, Antibodies, a Laboratory Manual. Cold Spring Harbor Laboratory, New York, pp. 359-420.
8. Suzuki, S., Enosawa, S., Kakefuda, T., Shinomiya, T., Amari, M., Naoe, S., Hoshino, Y. and Chiba K. 1996a. A novel immunosuppressant, FTY720, having an unique mechanism of action induces long-term graft acceptance in rat and dog allotransplantation. Transplantation, in press.
9. Suzuki, S., Enosawa, S., Kakefuda, T., Amemiya, H., Hoshino, Y., Chiba, K., 1996b. Long-term graft acceptance in allografted rats and dogs by treatment with novel immunosuppressant, FTY720. Transplant Proc.; in press.
10. Suzuki, S., Xiao-Kang L., Shinomiya, T., Enosawa, S., Kakefuda, T., Mitsusada, M., Amemiya, H., Takahara, S., Amari, M., Naoe, S., Hoshino, Y. and Chibam K., 1996c. Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720. Transplant Proc.; in press.
11. Tsunawaki, S., Kaneda, M. and Kakinuma K., 1983. Activation of guinea pig polymorphonuclear leukocytes with soluble stimulators leads to nonrandom distribution of NADPH oxidase in the plasma membrane. J. Biochem. 94: 655-664.